Impact Factor
3.05
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.54
123 total citations
h5-index
18
h5 depth signal
Cited share
80.4%
45 of 56
Total citations
123
Citation footprint
Metric signal
1.62
External metric anchor
Self-citation
0.0%
0 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
China
258
Canada
88
United States
56
Japan
28
Turkey
27
Citing Fields of Research
Respiratory Support
198
Allergies
168
Lung Cancer
132
Auto-Inflammatory Disorders
66
Chronobiology
41
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
2,013
Articles tracked across the journal lifetime
Indexed publication set
56
45 cited publications
Last 12 months
78
78.0 publications/month
Open access share
100.0%
78 OA publications in the last year
Leading citing country
China
258 citing publications
Leading citing field
Respiratory Support
198 citing publications
Latest tracked publication
31 January 2026
10 recent records available
Coverage & Indexing History
v5n1, Jan./Feb. 1998-
v5n1, Jan./Feb. 1998-
Active Coverage
Active Coverage
Research Focus & Classification
Indexed Subjects
Respiratory Support
Auto-Inflammatory Disorders
Lung Cancer
Allergies
Cystic Fibrosis
Issuing & Sponsoring Bodies
Contributor
Canadian Thoracic Society
Broad Categories
Pulmonary Medicine
Allergies
Respiratory Support
Lung Cancer
Cardiology
Auto-Inflammatory Disorders
MeSH Descriptors
Respiratory Tract Diseases
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1155/carj/5208730
Open DOI
Genetically Raised Circulating Levels of Dietary Antioxidants and the Association With Respiratory Health in High‐Risk Populations
Background: Observational studies of raised dietary antioxidants suggest a beneficial effect on respiratory health; however, findings from interventional trials have been inconsistent or null. Few studies have specifically targeted indiv...
02
DOI 10.1155/carj/6614209
Open DOI
Yifei Decoction Regulates the NGF/TRKA/PI3K/AKT Signaling Axis to Inhibit the Epithelial–Mesenchymal Transformation and Proliferation of Pulmonary Epithelial Cells in Bleomycin‐Induced Pulmonary Fibrogenesis
Background: It was important to find better therapeutic drugs for idiopathic pulmonary fibrosis (IPF), and in our previous study, Yifei decoction (YFT) alleviated IPF. A deeper understanding of its mechanisms of action could aid in the d...
03
DOI 10.1155/carj/7829487
Open DOI
Asthma in Patients With Confirmed Pulmonary Sarcoidosis
Pulmonary sarcoidosis and asthma can present identical symptoms, making clinical evaluation difficult if the two diseases overlap. Diagnostic challenges often lead to either overdiagnosis of asthma in patients with confirmed sarcoidosis ...
04
DOI 10.1155/carj/9063636
Open DOI
The Impact of Chronic Kidney Disease on In‐Hospital Outcomes in Patients With Acute Respiratory Distress Syndrome
Background: Acute respiratory distress syndrome (ARDS) is associated with high mortality rates in critically ill patients. Renopulmonary interplay remains crucial in contributing to the outcomes in patients with ARDS. While the role of a...
05
DOI 10.1155/carj/1049336
Open DOI
Integrated Mendelian Randomization and Single‐Cell RNA Sequencing Analyses Reveal Lactate Metabolism as a Key Pathway in COVID‐19‐Induced Pulmonary Fibrosis
Background: The COVID‐19 pandemic has led to a variety of long‐term complications, with COVID‐19‐induced idiopathic pulmonary fibrosis (IPF) becoming a major concern. However, the underlying mechanisms, effective therapeutic strategies, ...
06
DOI 10.1155/carj/9485331
Open DOI
TAPI‐1 Combined With Silicone Stents Alleviated Severe Traumatic Tracheal Stenosis via the ADAM17/TGF‐β1 Pathway
Background: Traumatic tracheal stenosis is characterized by airway granular proliferation after trauma, which may lead to asphyxy. Abnormal activation of the ADAM17/TGF‐β1 pathway may trigger excessive repair and airway fibrosis. TAPI‐1 ...
07
DOI 10.1155/carj/8812779
Open DOI
Efficacy and Safety of Pirfenidone for Mitigation of Interstitial Lung Abnormalities in COVID‐19 Patients: A Meta‐Analysis
Background: Although post‐COVID‐19 interstitial lung abnormalities (ILAs) are common, the use of antifibrotic agents to prevent their onset and progression is controversial. We aimed to investigate the effectiveness and safety of pirfeni...
08
DOI 10.1155/carj/9923052
Open DOI
Assessing the Impact of Colchicine on Pulmonary Fibrosis Using Imaging in Patients With Moderate‐to‐Severe COVID‐19 Pneumonia
Objective: Pulmonary fibrosis may develop in patients with severe clinical conditions, especially those with high inflammatory indicators. We aimed to investigate the 15‐month follow‐up clinical outcomes in patients with moderate‐to‐seve...
09
DOI 10.1155/carj/6968736
Open DOI
Systemic Inflammatory Response Index Has a Value for the Early Diagnosis and Short‐Term Prognostic Assessment of Severe Pneumonia in the Elderly
This article probed the value of systemic inflammatory response index (SIRI) in the early diagnosis and short‐term prognostic assessment of severe pneumonia (SPM) in the elderly. First, 266 elderly patients with pneumonia were retrospect...
10
DOI 10.1155/carj/4397833
Open DOI
Oroxylin A From Scutellaria baicalensis Improved Pulmonary Fibrosis of Radiation Pneumonia Through Ferroptosis by Nrf2
Radiation pneumonitis can result in respiratory dysfunction and progress to radiation fibrosis, and in severe cases, respiratory failure may occur. Hence, we investigated the effects of Oroxylin A from Scutellaria baicalensis in radiatio...
Bibliographical & Catalog Notes
Title from cover.
Print issues ceased with v. 22, no. 6 (2015).
Also issued online.
Articles in English; summaries in English and French.
Official journal of the Canadian Thoracic Society.